Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry ...
Preview this article 1 min Personalis shareholders will receive $16.25 per share. The deal is expected to close in late 2026 ...
MarketBeat on MSN
Tempus AI bets on MRD testing growth with Personalis acquisition
Key Points Interested in Tempus AI, Inc.? Here are five stocks we like better. Tempus AI plans to acquire Personalis to ...
Check out the latest Tempus Ai Inc (TEM) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.
The AI in pathology market is witnessing strong growth, driven by the increasing adoption of digital pathology, rising cancer incidence, and the growing demand for faster and more accurate diagnostic ...
On July 1, Freedom Capital initiated coverage of Tempus AI, Inc. (NASDAQ:TEM) with a Hold rating. The firm gave a $59 price ...
Tempus AI, Inc. (NASDAQ:TEM) is one of the 8 Best Genomics Stocks to Buy According to Analysts. On June 3, Tempus AI, Inc. (NASDAQ:TEM) reported that it launched an open-source digital pathology ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced publication of successful multi-site validation ...
Tempus AI is building one of the largest healthcare data platforms in the industry, combining artificial intelligence with vast amounts of clinical information. As more data enters the system, the ...
Great. Good afternoon, everyone. I'm Evie Koslosky, the Life Science Tools and Diagnostics Analyst here at Goldman Sachs. I'm joined here with Eric Lefkofsky, the CEO of Tempus AI. Thank you so much ...
Aristotle Capital Management, LLC, an investment management company, released its “Core Equity Fund” first-quarter 2026 investor letter. A copy of the letter can be downloaded here. During the first ...
- Proceeds expected to be used to repay in full outstanding loans under the senior secured credit facilities, reducing interest expense and enhancing financial flexibility. Additional proceeds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results